COVID‐19 and the pulmonary complications of sickle cell disease
Abstract Sickle cell disease (SCD) patients are commonly affected by pulmonary complications such as acute chest syndrome (ACS), pulmonary embolism (PE) and pneumonia that contribute to significant mortality risks. With a greater susceptibility to infection, they are deemed to be vulnerable patients...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2020-11-01
|
| Sarja: | eJHaem |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/jha2.105 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|